11 connected strategy in the healthcare industry providers to measure the clinical value of its programs. Today, Omada has a whole pack- age of scientific data establishing the clinical effectiveness of its programs in helping patients prevent diabetes as well as manage Type II diabetes after diagnosis. Omada has a number of well-regarded, peer-reviewed publications, clinical trials, and case studies that establish its efficacy as a digital therapeutic.18,19 In 2016, Omada was the first digital health company to receive coverage and reimbursement from the U.S. federal government, the Center for Medicare and Medicaid Services, for its diabetes platform, which is a significant milestone for broad acceptance and credibility of its program in the medical community.20 This also sets an important precedent for other large health in- surers to provide coverage and reimbursement for Omada as well. Additionally, in 2018, the Center for Disease Control and Prevention granted Omada’s diabetes management platform full recognition status, which is a critical validation from a regulatory body for its proprietary curriculum.21 As of 2021, the company is the largest CDC-recognized provider of the National Diabetes Prevention Program. With all of this scientific evidence and regulatory recognition as key evidence of success, Omada has 350,000 enrolled participants and over 1,000 enterprise customers, making it one of the largest diabetes programs in the US.22 Given that the company is not yet public, it is hard to determine if Omada has reached traditional, financial metrics of success in terms of profitability, but its current path suggests that it may be there or is on its way. While Omada has reached key milestones of success for its diabetes platform, it is still yet to be determined if it will be able to reach the same level of success in its expanded offerings in hypertension, mental health, and musculoskeletal issues. Instead of expand- ing into new patient populations, Omada could have considered evolving its connected strategy and investing in automatic execution capabilities to deepen its connected customer experience. As will be explored in later case studies, there are a handful of diabetes platforms with connected strategies that are finding success. Omada needs to keep evolving its connected strategy to maintain its competitive edge and it is currently unclear whether or not Omada will be able to do that as more companies gain traction in this space. 18 https://www.omadahealth.com/en/omada-resources 19 https://www.mobihealthnews.com/content/omada-health-launch-largest-clinical-trial-digital-dpp 20 https://www.mobihealthnews.com/content/medicare-reimburse-diabetes-prevention-program-including-omadas-digital-version 21 https://www.mobihealthnews.com/content/digital-health-news-briefs-5312018 22 https://medcitynews.com/2020/03/is-an-omada-health-ipo-inevitable/